Stockscreener 앱 받기
8.07
1.00%
0.06
전일 마감가:
$8.01
열려 있는:
$8
하루 거래량:
1.13M
Relative Volume:
0.50
시가총액:
$764.58M
수익:
-
순이익/손실:
$-258.08M
주가수익비율:
-2.9345
EPS:
-2.75
순현금흐름:
$-202.32M
1주 성능:
+12.99%
1개월 성능:
+58.01%
6개월 성능:
-52.94%
1년 성능:
-65.53%
1일 변동 폭
$7.84
$8.19
1주일 범위
$7.01
$8.26
52주 변동 폭
$4.55
$26.98
Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile
명칭
Rocket Pharmaceuticals Inc
전화
646-440-9100
주소
350 FIFTH AVENUE, NEW YORK, NY
RCKT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RCKT
Rocket Pharmaceuticals Inc
|
8.09 | 764.58M | 0 | -258.08M | -202.32M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.49 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
605.00 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.39 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
269.33 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.48 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-12 | 개시 | BMO Capital Markets | Outperform |
| 2024-12-30 | 개시 | Wedbush | Outperform |
| 2024-12-18 | 개시 | Jefferies | Buy |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-04-02 | 개시 | Goldman | Neutral |
| 2023-10-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-02-01 | 개시 | Morgan Stanley | Overweight |
| 2022-11-08 | 개시 | Canaccord Genuity | Buy |
| 2022-11-01 | 개시 | BTIG Research | Buy |
| 2022-07-08 | 개시 | Raymond James | Outperform |
| 2021-10-20 | 재개 | Cowen | Outperform |
| 2021-03-02 | 개시 | Stifel | Buy |
| 2021-02-18 | 개시 | Needham | Buy |
| 2020-12-16 | 개시 | UBS | Buy |
| 2020-12-08 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-07-02 | 개시 | JP Morgan | Overweight |
| 2020-06-25 | 재개 | BofA/Merrill | Buy |
| 2020-06-01 | 재개 | Oppenheimer | Outperform |
| 2019-11-06 | 개시 | Chardan Capital Markets | Buy |
| 2019-09-26 | 개시 | Piper Jaffray | Overweight |
| 2019-04-23 | 개시 | Robert W. Baird | Outperform |
| 2019-03-15 | 개시 | BofA/Merrill | Buy |
| 2019-02-05 | 개시 | Oppenheimer | Outperform |
| 2018-09-13 | 개시 | Ladenburg Thalmann | Buy |
| 2018-07-10 | 개시 | William Blair | Outperform |
모두보기
Rocket Pharmaceuticals Inc 주식(RCKT)의 최신 뉴스
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Stock: A Value Hunter’s Investment? - Stocksregister
Wells Fargo & Company MN Buys 10,147 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Trading (RCKT) With Integrated Risk Controls - news.stocktradersdaily.com
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
Rocket Pharmaceuticals (RCKT) Expected to Announce Quarterly Earnings on Monday - Defense World
Rocket Pharmaceuticals Inc (RCKT) Stock: A Year of Stock Market Dynamics - investchronicle.com
RCKT stock touches 52-week low at $9.76 amid market challenges - MSN
Rocket Pharmaceuticals Inc [RCKT] Records 50-Day SMA of $7.76 - knoxdaily.com
Top investors say Rocket Pharmaceuticals Inc (RCKT) ticks everything they need - Sete News
Rocket Pharmaceuticals Inc (RCKT)’s Market Momentum: Closing Strong at 7.16, Down -0.97 - DWinneX
Rocket Pharmaceuticals Inc (RCKT) stock analysis: A simple moving average approach - uspostnews.com
Rocket Pharmaceuticals Inc [RCKT] Insider Activity: An Update for Investors - knoxdaily.com
Is Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Stock Worth Investing In for High Returns? - Marketing Sentinel
Rocket Pharmaceuticals appoints new board member - MSN
RCKT stock touches 52-week low at $10.11 amid market challenges - MSN
Rocket Pharmaceuticals Inc (NASDAQ:RCKT) Could Actually Go To 39 In 12 Months - Marketing Sentinel
Understanding the Risks of Investing in Rocket Pharmaceuticals Inc (RCKT) - knoxdaily.com
Financial Metrics Exploration: Understanding Rocket Pharmaceuticals Inc (RCKT) Through Ratios - DWinneX
The Future of Rocket Pharmaceuticals Inc: Analyzing RCKT - investchronicle.com
Rocket Pharmaceuticals Inc [RCKT] Revenue clocked in at $0.00 million, down -42.96% YTD: What’s Next? - dbtnews.com
Our Attention Has Been Attracted to Rocket Pharmaceuticals Inc (NASDAQ:RCKT) - uspostnews.com
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Sold by Alliancebernstein L.P. - Defense World
Geode Capital Management LLC Increases Stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
(RCKT) Trading Report - news.stocktradersdaily.com
JPMorgan Chase & Co. Sells 41,024 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
3 Stocks Insiders Are Buying Rapidly Amid Market Volatility - Investing.com
Is Rocket Pharmaceuticals (NASDAQ:RCKT) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Countdown To Approval: Rocket Pharma's Gene Therapy For Rare Disease Awaits FDA Decision - RTTNews
Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Gap Up After Insider Buying Activity - Defense World
Rocket Pharmaceuticals CEO Gaurav Shah acquires $101,600 in stock By Investing.com - Investing.com UK
Rocket Pharmaceuticals CEO buys $101.6K in common stock - MSN
Rocket Pharmaceuticals CEO Gaurav Shah acquires $101,600 in stock - Investing.com Australia
If You Don’t Buy Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Now, You’ll Kick Yourself Later - stocksregister.com
Raymond James Financial Inc. Makes New $285,000 Investment in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Rocket Pharmaceuticals (NASDAQ:RCKT) Earns Buy Rating from Needham & Company LLC - Defense World
Rocket Pharmaceuticals executive Kinnari Patel buys $99,165 in stock By Investing.com - Investing.com South Africa
Rocket Pharmaceuticals executive Kinnari Patel buys $99,165 in stock - Investing.com
Rocket Pharma Out Of Orbit, But Ready For Re-Launch (NASDAQ:RCKT) - Seeking Alpha
The Escalator: Rocket Pharmaceuticals, Zenas BioPharma, Angelini Ventures - Medical Marketing and Media
Corebridge Financial Inc. Sells 2,469 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Vanguard Group Inc. Purchases 1,040,655 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Rocket Pharmaceuticals (RCKT): Among Stocks Under $10 that Will Triple - Insider Monkey
KLP Kapitalforvaltning AS Buys Shares of 15,300 Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Rocket Pharmaceuticals CFO sells $39,646 in stock By Investing.com - Investing.com India
Rocket Pharmaceuticals CFO sells $39,646 in stock - Investing.com
Rocket Pharmaceuticals CFO Sells Shares to Cover Tax Obligations - TradingView
10 Stocks Under $10 that Will Triple - Insider Monkey
BMO maintains Rocket Pharmaceuticals Outperform rating By Investing.com - Investing.com UK
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Rocket Pharmaceuticals appoints new Chief Officer By Investing.com - Investing.com Canada
Rocket Pharmaceuticals appoints new Chief Officer - Investing.com Australia
Rocket Pharmaceuticals Inc (RCKT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.27%
0.30%
자본화:
|
볼륨(24시간):